Director, Internal Communication, Europe
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
The Director, Internal Communications, Europe, will shape and deliver clear, engaging communications that connect employees with the organisation’s culture, strategy and priorities. Working closely with global and regional stakeholders, the role will translate complex initiatives into actionable communications for country teams.
This is an intentionally broad remit, spanning a wide range of disciplines. We are realistic that priorities will need to be set and will evolve over time. We are
